Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.8 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |